These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 27000256

  • 1. Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
    Becker J, Callegaro D, Lana-Peixoto MA, Talim N, Vidaletti T, de Paula Corrêa M, Gomes I.
    J Neurol Sci; 2016 Apr 15; 363():236-9. PubMed ID: 27000256
    [Abstract] [Full Text] [Related]

  • 2. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
    Brola W, Sobolewski P, Szczuchniak W, Góral A, Fudala M, Przybylski W, Opara J.
    Eur J Clin Nutr; 2016 Sep 15; 70(9):995-9. PubMed ID: 27026420
    [Abstract] [Full Text] [Related]

  • 3. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
    Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A.
    Mult Scler; 2005 Jun 15; 11(3):266-71. PubMed ID: 15957505
    [Abstract] [Full Text] [Related]

  • 4. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I.
    J Neurol Neurosurg Psychiatry; 2008 Feb 15; 79(2):152-7. PubMed ID: 17578859
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E, Orsini M, Daures JP, Camu W.
    Eur J Neurol; 2015 Mar 15; 22(3):564-9. PubMed ID: 25530281
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
    Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB.
    Mult Scler Relat Disord; 2016 Nov 15; 10():169-173. PubMed ID: 27919484
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.
    Rito Y, Flores J, Fernández-Aguilar A, Escalante-Membrillo C, Barboza MA, Amezcua L, Corona T.
    Acta Neurol Belg; 2018 Mar 15; 118(1):47-52. PubMed ID: 28975580
    [Abstract] [Full Text] [Related]

  • 8. Bone metabolism and vitamin D status in patients with multiple sclerosis.
    Kępczyńska K, Zajda M, Lewandowski Z, Przedlacki J, Zakrzewska-Pniewska B.
    Neurol Neurochir Pol; 2016 Mar 15; 50(4):251-7. PubMed ID: 27375138
    [Abstract] [Full Text] [Related]

  • 9. Multiple sclerosis and vitamin D during pregnancy and lactation.
    Jalkanen A, Kauko T, Turpeinen U, Hämäläinen E, Airas L.
    Acta Neurol Scand; 2015 Jan 15; 131(1):64-7. PubMed ID: 25216350
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D, vitamin D binding protein, vitamin D receptor levels and cardiac dysautonomia in patients with multiple sclerosis: a cross-sectional study.
    Aktürk T, Turan Y, Tanik N, Karadağ ME, Sacmaci H, Inan LE.
    Arq Neuropsiquiatr; 2019 Dec 15; 77(12):848-854. PubMed ID: 31939581
    [Abstract] [Full Text] [Related]

  • 11. Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis.
    Triantafyllou N, Lambrinoudaki I, Thoda P, Andreadou E, Kararizou E, Alexandrou A, Limouris G, Antoniou A, Tsivgoulis G.
    J Neurol Sci; 2012 Feb 15; 313(1-2):137-41. PubMed ID: 21992813
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
    Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M, SOLAR study group.
    J Neurol Sci; 2011 Dec 15; 311(1-2):44-9. PubMed ID: 21620416
    [Abstract] [Full Text] [Related]

  • 13. The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
    Babaloo Z, Aliparasti MR, Babaiea F, Almasi S, Baradaran B, Farhoudi M.
    Immunol Lett; 2015 Apr 15; 164(2):76-80. PubMed ID: 25625963
    [Abstract] [Full Text] [Related]

  • 14. Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.
    Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M.
    J Neurol Neurosurg Psychiatry; 2013 Oct 15; 84(10):1075-81. PubMed ID: 23385850
    [Abstract] [Full Text] [Related]

  • 15. Association of vitamin D status with multiple sclerosis in a case-control study from Morocco.
    Skalli A, Ait Ben Haddou EH, El Jaoudi R, Razine R, Mpandzou GA, Tibar H, El Fahime E, Bouslam N, Alami A, Benomar A, Hajjout K, Yahyaoui M, Bouhouche A.
    Rev Neurol (Paris); 2018 Mar 15; 174(3):150-156. PubMed ID: 29525037
    [Abstract] [Full Text] [Related]

  • 16. Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
    Alroughani RA, Akhtar S, Ahmed SF, Al-Hashel JY.
    Int J Neurosci; 2015 Mar 15; 125(11):831-7. PubMed ID: 25329929
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
    Simpson S, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I.
    Ann Neurol; 2010 Aug 15; 68(2):193-203. PubMed ID: 20695012
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.